Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
113 valent conjugated pneumococcal vaccine----[1] 265
2150 mg GSK1265744B----[1] 265
3300mg Gemcabene[1] Gemcabene---[1] 265
43TC----[2] 265, 325
5600mg Gemcabene[1] Gemcabene---[1] 265
6Abacavir[1] Abacavir[2] D00891 ,
D07057 		--[4] 2, 135, 265, 325
7Abacavir 300mg twice daily[1] Abacavir[2] D00891 ,
D07057 		--[1] 265
8Abacavir sulfate[2] Abacavir,
Sulfate ion		[2] D00891 ,
D07057 		--[1] 265
9Abacavir sulfate, Lamivudine and Zidovudine[4] Abacavir,
Lamivudine,
Sulfate ion,
Zidovudine		[4] D00353 ,
D00413 ,
D00891 ,
D07057 		--[1] 265
10ABC----[2] 265, 325
11Acetate[1] Acetate---[43] 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
12ACETYL- L- CARNITINE[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713 		--[1] 265
13Acetylcarnitine[1] Acetylcarnitine---[2] 2, 265
14Acipimox[1] Acipimox[1] D07190 --[2] 78, 265
15AKCEA-ANGPTL3-LRX----[2] 79, 265
16Amprenavir[1] Amprenavir[1] D00894 --[1] 265
17Antiretroviral/Anti HIV----[1] 265
18Aramchol[1] Aramchol---[1] 265
19Atazanavir[1] Atazanavir[2] D01276 ,
D07471 		--[1] 265
20Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)[2] Atazanavir,
Ritonavir		[3] D00427 ,
D01276 ,
D07471 		--[1] 265
21Atazanavir (Reyataz)[1] Atazanavir[2] D01276 ,
D07471 		--[1] 265
22Atazanavir/Ritonavir[2] Atazanavir,
Ritonavir		[3] D00427 ,
D01276 ,
D07471 		--[1] 265
23Atorvastatin[1] Atorvastatin[3] D00258 ,
D00887 ,
D07474 		[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[18] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299
24Atorvastatin Calcium[2] Atorvastatin,
Calcium		[3] D00258 ,
D00887 ,
D07474 		[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[2] 97, 265
25ATV----[1] 265
26Avandia administration for 6-12 weeks----[1] 265
27AZT----[3] 94, 265, 325
28AZT/3TC----[1] 265
29Baricitinib[1] Baricitinib[1] D10308 [2] JAK1,
JAK2 💬		[35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[13] 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
30Behavioral: 60-minutes of steady state exercise----[1] 265
31Behavioral: Diet----[1] 265
32Behavioral: Exercise----[3] 6, 265, 299
33Behavioral: Exercise Training----[1] 265
34Berberine[1] Berberine---[2] 97, 265
35BMS-232632----[1] 265
36Caffeine[1] Caffeine[2] D00528 ,
D01453 		[11] ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬		[22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[9] 2, 6, 13, 21, 46, 78, 96, 97, 265
37Calcium[1] Calcium---[30] 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299
38Carnitine[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713 		--[9] 5, 13, 58, 86, 96, 97, 265, 298, 316
39CD----[7] 6, 13, 46, 51, 96, 97, 265
40CD-4 guided therapy interruption----[1] 265
41Cholic Acid[1] Cholic Acid[1] D10699 [1] NR1H4 💬[1] Bile secretion 💬[4] 20, 234, 265, 310
42CoFactor----[3] 6, 265, 288
43Cofactor supplementation (thiamine, riboflavin, L-carnitine)[3] Levocarnitine,
Riboflavin,
Thiamine		[7] D00050 ,
D01622 ,
D01913 ,
D02030 ,
D02176 ,
D04713 ,
D08580 		--[1] 265
44COMBIVIR[1] Zidovudine[1] D00413 --[1] 265
45Combivir (zidovudine [AZT] / lamivudine [3TC])[2] Lamivudine,
Zidovudine		[2] D00353 ,
D00413 		--[1] 265
46Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----[1] 265
47Cyclophosphamide[1] Cyclophosphamide[2] D00287 ,
D07760 		--[45] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331
48Didanosine[1] Didanosine[1] D00296 --[2] 25, 265
49Different HAART regimens----[1] 265
50DIOSMIN[1] Diosmin[1] D07858 --[1] 265
51Diosminex, 500 mg, tabletki powlekane----[1] 265
52Dolutegravir[1] Dolutegravir[1] D10066 --[2] 2, 265
53Dolutegravir / Lamivudine Oral Tablet[2] Dolutegravir,
Lamivudine		[2] D00353 ,
D10066 		--[1] 265
54Dolutegravir 50 MG[1] Dolutegravir[1] D10066 --[1] 265
55Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO][1] Lamivudine[1] D00353 --[1] 265
56Doravirine[1] Doravirine[1] D10624 --[1] 265
57Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO][4] Doravirine,
Lamivudine,
Tenofovir,
Tenofovir disoproxil		[4] D00353 ,
D01982 ,
D06074 ,
D10624 		--[1] 265
58Efavirenz[1] Efavirenz[1] D00896 --[1] 265
59Efavirenz (EFV)[1] Efavirenz[1] D00896 --[1] 265
60Emtricitabine[1] Emtricitabine[1] D01199 --[4] 25, 93, 265, 325
61Emtricitabine/tenofovir[2] Emtricitabine,
Tenofovir		[2] D01199 ,
D06074 		--[1] 265
62Enfuvirtide[1] Enfuvirtide[1] D02499 --[2] 25, 265
63Enfuvirtide (T20)[1] Enfuvirtide[1] D02499 --[1] 265
64Fenofibrate[1] Fenofibrate[1] D00565 [1] PPARA 💬[10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[5] 8, 79, 93, 94, 265
65Gemcabene[1] Gemcabene---[2] 79, 265
66Genetic: Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----[1] 265
67Genotropin (human recombinant Growth hormone)[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 265
68Glycerine[1] Glycerin[1] D00028 --[1] 265
69Growth hormone[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[13] 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 299
70Growth Hormone Releasing Hormone[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 265
71GSK1265744B (sodium salt) containing 14C-GSK1265744B----[1] 265
72High-carbohdyrate breakfast----[1] 265
73High-dose REGN4461----[1] 265
74Hu Leptin (A-100)[1] Leptin---[1] 265
75Human Growth Hormone[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[4] 78, 187, 193, 265
76Human recombinant leptin (metreleptin)[2] Leptin,
Metreleptin		[1] D05014 [1] LEPR 💬[6] AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬[1] 265
77Indinavir[1] Indinavir[3] D00897 ,
D02861 ,
D03833 		--[1] 265
78ISIS 304801----[1] 265
79Kaletra (lopinavir [LPVr])[1] Lopinavir[1] D01425 --[1] 265
80L-Carnitine[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713 		--[7] 13, 86, 96, 97, 265, 298, 316
81L-Lactic acid[2] L-Lactic acid,
Lactic acid		[1] D00111 --[1] 265
82Lactic acid[1] Lactic acid[1] D00111 --[2] 265, 299
83Lamivudine[1] Lamivudine[1] D00353 --[7] 2, 26, 42, 46, 135, 265, 325
84Lamivudine/Zidovudine[2] Lamivudine,
Zidovudine		[2] D00353 ,
D00413 		--[1] 265
85Leptin[1] Leptin---[2] 6, 265
86Lopinavir[1] Lopinavir[1] D01425 --[1] 265
87Lopinavir/Ritonavir[2] Lopinavir,
Ritonavir		[2] D00427 ,
D01425 		--[1] 265
88Lopinavir/ritonavir + nevirapine[3] Lopinavir,
Nevirapine,
Ritonavir		[3] D00427 ,
D00435 ,
D01425 		--[1] 265
89Lopinavir/ritonavir + zidovudine + lamivudine[4] Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine		[4] D00353 ,
D00413 ,
D00427 ,
D01425 		--[1] 265
90Low-Dose REGN4461----[1] 265
91Mecasermin[1] Mecasermin[2] D03297 ,
D04870 		[2] GHR,
IGF1R 💬		[33] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬[5] 78, 96, 168, 265, 299
92Metformin[1] Metformin[2] D00944 ,
D04966 		[2] PRKAA1,
PRKAA2 💬		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[24] 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
93METFORMIN HYDROCHLORIDE[1] Metformin[2] D00944 ,
D04966 		[2] PRKAA1,
PRKAA2 💬		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[5] 81, 158, 265, 299, 301
94METRELEPTIN[1] Metreleptin[1] D05014 [1] LEPR 💬[6] AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬[1] 265
95Metrelpetin----[1] 265
96Monotherapy (Lopinavir/ritonavir)[2] Lopinavir,
Ritonavir		[2] D00427 ,
D01425 		--[1] 265
97Monotherapy (Lopinavir/ritonavir) + ABC/3TC[2] Lopinavir,
Ritonavir		[2] D00427 ,
D01425 		--[1] 265
98Myalept[1] Metreleptin[1] D05014 [1] LEPR 💬[6] AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬[1] 265
99N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate[2] Acetate,
Somatotropin		[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 265
100Nelfinavir[1] Nelfinavir[2] D00899 ,
D08259 		--[3] 49, 265, 331
101Nelfinavir mesylate[1] Nelfinavir[2] D00899 ,
D08259 		--[1] 265
102Nevirapine[1] Nevirapine[1] D00435 --[1] 265
103Niacin[1] Niacin[1] D00049 --[3] 6, 78, 265
104Non-nucleoside reverse transcriptase inhibitors----[1] 265
105Norvir[1] Ritonavir[1] D00427 --[2] 265, 299
106NucleomaxX----[1] 265
107Nucleoside analogue sparing HAART regimen----[1] 265
108Nucleoside reverse transcriptase inhibitors----[1] 265
109Obeticholic Acid[1] Obeticholic acid[1] D09360 [1] NR1H4 💬[1] Bile secretion 💬[3] 93, 265, 296
110Other: Glycerine gel[1] Glycerin[1] D00028 --[1] 265
111Other: Observation----[1] 265
112Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----[1] 265
113Pioglitazone[1] Pioglitazone[2] D00945 ,
D08378 		[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
114Pioglitazone or metformin[2] Metformin,
Pioglitazone		[4] D00944 ,
D00945 ,
D04966 ,
D08378 		[3] PPARG,
PRKAA1,
PRKAA2 💬		[27] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬[1] 265
115Pneumococcal polysaccharide vaccine 23 valent----[1] 265
116POLY-L-LACTIC ACID[3] L-Lactic acid,
Lactic acid,
Poly(lactic acid)		[1] D00111 --[1] 265
117Pravastatin[1] Pravastatin[2] D00893 ,
D08410 		[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[9] 13, 46, 49, 67, 79, 96, 164, 265, 333
118Pravastatin sodium[1] Pravastatin[2] D00893 ,
D08410 		[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 265
119Prevenar13----[2] 19, 265
120Protease inhibitor----[1] 265
121Protease inhibitors----[1] 265
122R-metHuLeptin[1] Metreleptin[1] D05014 [1] LEPR 💬[6] AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬[1] 265
123Raltegravir[1] Raltegravir[1] D06676 --[4] 13, 26, 93, 265
124RECOMBINANT HUMAN GROWTH HORMONE[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 78, 193, 265
125Recombinant human growth hormone + rosiglitazone[2] Rosiglitazone,
Somatotropin		[3] D00596 ,
D02691 ,
D08491 		[2] GHR,
PPARG 💬		[16] AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 265
126REGN4461----[1] 265
127Reyataz[1] Atazanavir[2] D01276 ,
D07471 		--[1] 265
128REYATAZ 150MG 60 CPS BL[1] Atazanavir[2] D01276 ,
D07471 		--[1] 265
129Riboflavin[1] Riboflavin[3] D00050 ,
D01622 ,
D01913 		--[8] 13, 38, 46, 96, 97, 162, 168, 265
130Ritonavir[1] Ritonavir[1] D00427 --[3] 2, 86, 265
131Ritonavir (Norvir)[1] Ritonavir[1] D00427 --[1] 265
132Rosiglitazone[1] Rosiglitazone[2] D00596 ,
D08491 		[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[5] 46, 75, 97, 222, 265
133Rosiglitazone maleate[1] Rosiglitazone[2] D00596 ,
D08491 		[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[3] 46, 75, 265
134RTV----[1] 265
135Saquinavir[1] Saquinavir[2] D00429 ,
D01160 		--[2] 86, 265
136Serostim®[somatropin (rDNA origin) for injection][1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 265
137Setmelanotide[1] Setmelanotide[1] D11927 [1] MC4R 💬[1] Neuroactive ligand-receptor interaction 💬[2] 202, 265
138Simvastatin[1] Simvastatin[1] D00434 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[21] 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310
139Somatropin[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[19] 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
140ST200----[1] 265
141Standard continuous antiretroviral therapy----[1] 265
142Stavudine[1] Stavudine[1] D00445 --[1] 265
143Sulfate[1] Sulfate ion---[27] 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299
144SUSTIVA[1] Efavirenz[1] D00896 --[1] 265
145TAT4 Gel concentration A----[1] 265
146TAT4 Gel concentration B----[1] 265
147Tenofovir[1] Tenofovir disoproxil[1] D01982 --[6] 2, 13, 25, 93, 265, 325
148Tenofovir DF[1] Tenofovir[1] D06074 --[1] 265
149Tenofovir disoproxil[1] Tenofovir disoproxil[1] D01982 --[2] 93, 265
150Tenofovir Disoproxil Fumarate[2] Tenofovir,
Tenofovir disoproxil		[2] D01982 ,
D06074 		--[1] 265
151Tesamorelin[1] Tesamorelin[1] D06655 [1] GHRHR 💬[2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬[2] 78, 265
152Tesamorelin (Egrifta)[1] Tesamorelin[1] D06655 [1] GHRHR 💬[2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬[1] 265
153Testosterone[1] Testosterone[6] D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		[1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[9] 1, 2, 3, 13, 60, 76, 78, 113, 265
154Testosterone injection[1] Testosterone[6] D00075 ,
D00957 ,
D00958 ,
D00959 ,
D06085 ,
D06087 		[1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 265
155TH9507----[1] 265
156Thiamine[1] Thiamine[1] D08580 --[4] 8, 13, 93, 265
157Tipranavir[1] Tipranavir[2] D03843 ,
D08605 		--[1] 265
158Total Dietary Replacement----[1] 265
159TRUVADA[1] Emtricitabine[1] D01199 --[1] 265
160Use of lipid-lowering drugs.----[1] 265
161Venus Versa----[1] 265
162Viral load driven treatment interruption----[1] 265
163Volanesorsen[1] Volanesorsen[1] D11648 [1] APOC3 💬[2] Cholesterol metabolism, PPAR signaling pathway 💬[1] 265
164VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide[1] Volanesorsen[1] D11648 [1] APOC3 💬[2] Cholesterol metabolism, PPAR signaling pathway 💬[1] 265
165Zidovudine[1] Zidovudine[1] D00413 --[6] 25, 26, 135, 265, 325, 331